Dr. Schlechter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Boston, MA 02215Phone+1 857-215-0430- Is this information wrong?
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2008 - 2011
Tel Aviv University SacklerClass of 2008
Certifications & Licensure
MA State Medical License 2012 - 2025
Clinical Trials
- Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer Start of enrollment: 2019 Apr 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancer.Andrew H Ko, Andrew L Coveler, Benjamin L Schlechter, Tanios Bekaii-Saab, Brian M Wolpin, Jeffrey W Clark, Bruno Bockorny, Li-Yuan Bai, Yu-Chin Lin, Evelyn Chiang, Pet...> ;Investigational New Drugs. 2024 Apr 1
- RAS/RAF co-mutation and ERBB2 copy number modulates HER2 heterogeneity and responsiveness to HER2-directed therapy in colorectal cancer.Singh, H., Sahgal, P., Kapner, K., Corsello, S., Gupta, H., Gujrathi, R., Li, Y., Cherniack, A., El Alam, R., Kerfoot, J., Andrews, E., Lee, A., Nambiar, C., Hannigan,...> ;Clinical Cancer Research. 2024 Feb 12
- Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders.Huffman, B., Singh, H., Ali, L., Horick, N., Wang, S., Hoffman, M., Metayer, K., Murray, S., Bird, A., Abrams, T., Biller, L., Chan, J., Meyerhardt, J., McCleary, N., ...> ;Journal for Immunotherapy of Cancer. 2024 Jan 25
- Join now to see all
Press Mentions
Triumvira Immunologics Presents Initial HER2-Positive Solid Tumor Clinical Data at ESMOSeptember 12th, 2022- 5 Signs of Colon Cancer Every Woman Should KnowMarch 22nd, 2021
- Triumvira Immunologics Highlights Positive Phase 1 Clinical Data on TAC01-HER2 in Solid Tumors at ASCO 2023 Annual MeetingJune 1st, 2023
Professional Memberships
- Member
Hospital Affiliations
Beth Israel Deaconess Medical CenterBoston, Massachusetts
Dana-Farber Cancer InstituteBoston, Massachusetts
Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
